There are many fledgling pharma stocks out there that are trading at higher multiples than ILNS without anywhere near the robust pipeline that ILNS has. For example, a pharma stock that I tracked was trading in pennies several years ago. They were on the verge of shutting their doors. An Angel investor came in and provided them with the much needed capital to keep going. They are now trading at over $6 per share. I can't tell you the stock because I would be in violation of TOS. They are in clinical trials with a very promising cancer drug. They are not close to FDA approval yet. They will eventually get to that point. They will most likely get approval to distribute in UK first, then the US after FDA approval. ILNS is following the exact same path.
News 
Market Data 
Discover 
AI
